Dev Prasad
Analyst at Lucid
Replay available
Acumen Pharmaceuticals, Inc. (ABOS) Q4 2025 Earnings Call
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) Q4 2025 earnings conference call, held 2026-03-26. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Eric Siemers
Chief Medical Officer
Mary Kate
Analyst at Citi (for Jeff Meacham)
Alex Ron
Head of Investor Relations
Matt Suga
CFO and Chief Business Officer
Jason Zemanski
Analyst at Bank of America
Dr. Jim Doherty
President and Chief Development Officer
Dan O'Connell
Chief Executive Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Acumen Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:03.055 Ladies and gentlemen, thank you for standing by. 00:00:03.055 -- 00:00:08.262 Welcome to the Acumen Farmer fourth quarter 2025 conference call 00:00:08.262 -- 00:00:10.024 and webcast. 00:00:10.024 -- 00:00:14.229 At this time, all participants are in a listen-only mode. 00:00:14.229 -- 00:00:18.255 After the speaker's presentation, there will be a question and answer session. 00:00:18.255 -- 00:00:24.302 And to ask a question during the session, you would need to press star 11 on your telephone. 00:00:24.302 -- 00:00:28.330 You will then hear an automated message of us and your hand is raised. 00:00:28.330 -- 00:00:32.456 And to withdraw your question, please press star 11 again. 00:00:32.456 -- 00:00:36.823 Please be advised that today's conference is being recorded. 00:00:36.823 -- 00:00:41.750 I would like now to turn the conference over to Alex Ron, head of investor relations. 00:00:41.750 -- 00:00:43.954 Please go ahead. 00:00:43.954 -- 00:00:48.420 Thanks, Michelle. Good morning and welcome to the Acumen conference call to discuss our 00:00:48.420 -- 00:00:54.226 business update and financial results for the year ended December 31st, 2025. 00:00:54.335 -- 00:00:57.841 With me today are Dan O'Connell, our Chief Executive Officer, Dr. 00:00:57.841 -- 00:01:02.809 Jim Doherty, our President and Chief Development Officer, and Matt Suga, our CFO and 00:01:02.809 -- 00:01:06.515 Chief Business Officer. They will have brief prepared remarks, and then we'll open the 00:01:06.515 -- 00:01:10.281 call for questions. Joining for the Q&A session, we also have Dr. 00:01:10.281 -- 00:01:13.286 Eric Siemers, our Chief Medical Officer. 00:01:13.286 -- 00:01:17.133 Before we begin, we encourage listeners to go to the Investors section of the...